(Axios) – A Food and Drug Administration expert panel on Friday is set to resume the pandemic-driven debate over how to make pulse oximeters more accurate for people with darker skin. Why it matters: There’s growing evidence that the devices don’t reliably detect low oxygen levels in Black patients, resulting in delayed care, missed diagnoses of hypoxemia and possibly worse outcomes. (Read More)